Omid Seidizadeh: Advancing Genomic Insights into Bleeding Disorders at ISTH 2026
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared a post on LinkedIn:
“It was a pleasure to attend the International Society on Thrombosis and Haemostasis (ISTH) 2026 and meet many colleagues, collaborators, and scientists working across the fields of hemostasis and thrombosis.
During the meeting, I presented our data on whole-exome sequencing in patients with low von Willebrand factor and also had the opportunity to discuss our work on estimating the global and population prevalence of coagulation disorders using large-scale genomic databases at the ISTH SSC Omics session.
It was a great week of science, discussions, and new ideas, and I look forward to seeing how these conversations develop in the coming years.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring